This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Mondelez (MDLZ) Q4 Earnings Miss Estimates, Revenues Beat Y/Y
by Vrishali Bagree
Mondelez's (MDLZ) fourth-quarter 2021 results reflect higher earnings and revenues, with the latter gaining on buyouts and strong organic revenues.
Diageo (DEO) 1H FY22 Earnings & Sales Improve on Robust Trends
by Zacks Equity Research
Diageo's (DEO) first-half fiscal 2022 results reflect gains from continued recovery in the on-trade channel, strong consumer demand in the off-trade and market share growth.
Colgate (CL) Earnings in Line, Sales Miss Estimates in Q4
by Zacks Equity Research
Colgate's (CL) Q4 results reflect strong business momentum, particularly in the oral care and pet nutrition categories. Results gain from price increases and stable volume amid ongoing supply woes.
Altria (MO) Q4 Earnings Match Estimates, Revenues Fall Y/Y
by Zacks Equity Research
Altria Group's (MO) fourth-quarter 2021 results reflect an increased bottom line, while the top line declines year over year. Pricing remains an upside.
Kimberly-Clark (KMB) Q4 Earnings Beat Estimates, Sales Up Y/Y
by Zacks Equity Research
Kimberly-Clark's (KMB) fourth-quarter 2021 earnings decline year over year. Nevertheless, the company's sales increased on improved volumes.
Inter Parfums (IPAR) Ups 2021 Earnings View on Solid Q4 Sales
by Zacks Equity Research
Inter Parfums' (IPAR) sales increase year over year in fourth-quarter 2021. Management raises 2022 sales and earnings guidance.
Nu Skin (NUS) Shines on Solid Sales Leaders & Customer Network
by Zacks Equity Research
Nu Skin Enterprises (NUS) has been benefiting from its efforts to empower sales leaders and strengthen the customer base.
Coty (COTY) Gains on Strategic Pillars & Solid Brand Portfolio
by Zacks Equity Research
Coty (COTY) has been benefiting from its six strategic pillars. Solid e-commerce performance and gains from alliances and agreements have been working well for the company.
Helen of Troy (HELE) Poised on Leadership Brands, Strategies
by Zacks Equity Research
Helen of Troy (HELE) is focused on making investments in its Leadership Brands. Management is progressing well with key growth areas under its Phase II Transformation efforts.
Service Corporation (SCI) Up on Solid Cemetery Unit, Expansions
by Zacks Equity Research
Service Corporation (SCI) is benefiting from robust revenues in its Cemetery segment. Also, the company's strategic investments are driving growth.
The Estee Lauder Companies (EL) Gains 38% in a Year: Here's Why
by Zacks Equity Research
The Estee Lauder Companies' (EL) Skin Care portfolio has been performing well for a while now. The company's online operations also look impressive.
Helen of Troy (HELE) Q3 Earnings Beat, Fiscal 2022 View Up
by Zacks Equity Research
Helen of Troy (HELE) Q3 reflects strong consumer and retailer demand for the Housewares and Beauty segments aiding core sales and earnings.
Helen of Troy (HELE) Tops Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Helen of Troy (HELE) delivered earnings and revenue surprises of 18.10% and 12.96%, respectively, for the quarter ended November 2021. Do the numbers hold clues to what lies ahead for the stock?
Factors to Note Before Helen of Troy's (HELE) Q3 Earnings
by Zacks Equity Research
Helen of Troy's (HELE) third-quarter fiscal 2022 results are likely to reflect escalated cost concerns, while strength in Leadership Brands is a key driver.
Helen of Troy (HELE) Adds Osprey, Strengthens Leadership Brands
by Zacks Equity Research
Helen of Troy (HELE) closes the buyout of Osprey Packs. It is likely to be an addition to the company's Leadership Brands' portfolio and is expected to augment the top and bottom lines.
Analysts Estimate Helen of Troy (HELE) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Helen of Troy (HELE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
General Mills (GIS) Divests Yoplait, Boosts Accelerate Strategy
by Zacks Equity Research
General Mills (GIS) offloads 51% controlling interest in its European Yoplait operations to Sodiaal as part of its Accelerate strategy.
Archer Daniels (ADM) Acquires Sojaprotein to Meet High Demand
by Zacks Equity Research
In a bid to meet the growing demand for alternative protein, Archer Daniels (ADM) concluded the buyout of Sojaprotein. The move is expected to be accretive to its nutrition segment.
Brand Strength to Offset Monster Beverages (MNST) Cost Woes?
by Zacks Equity Research
Monster Beverages (MNST) is likely to keep gaining from strength in the energy drinks category and commitment toward product innovation. Supply & logistics woes are likely to persist in the near term.
Coty (COTY) Gains on Growth in Online Sales, Core Beauty Units
by Zacks Equity Research
Coty's (COTY) Prestige and Consumer Beauty categories are doing well, backed by strong brand offerings and innovations. The e-commerce platform is also gaining traction.
Here's Why Hold Strategy is Apt for Colgate (CL) Right Now
by Zacks Equity Research
Colgate (CL) benefits from a strong product portfolio, innovation and expansion strategies. Higher freight costs and commodity cost inflation remain concerns.
Here's Why Newell (NWL) is Marching Ahead of Its Industry
by Zacks Equity Research
Although cost woes remain concerning, robust consumption patterns, higher demand and solid online show are likely to aid Newell (NWL).
Coty (COTY) On Track to Simplify Capital Structure With KKR Move
by Zacks Equity Research
Coty (COTY) announces the sale of KKR's 2.4% remaining ownership stake in the company. The move will further simplify Coty's balance sheet and reduce cost of capital.
Solid Nutrition Unit to Aid Archer Daniels (ADM) Amid Cost Woes
by Zacks Equity Research
Despite cost woes, Archer Daniels (ADM) is likely to continue gaining from healthy demand, strength in the Nutrition unit and other growth efforts, including its Readiness program.
Here's Why You Should Hold Procter & Gamble (PG) for Now
by Zacks Equity Research
Procter & Gamble (PG) remains well-poised on the back of brand strength, solid top-line growth and cost-saving plans. However, higher-than-anticipated commodity and freight costs are concerning.